Bluejay Diagnostics Files 8-K on Shareholder Votes
Ticker: BJDX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1704287
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
TL;DR
Bluejay Diagnostics filed an 8-K on shareholder votes, check for updates on corporate actions.
AI Summary
Bluejay Diagnostics, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of security holders as of June 18, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
Why It Matters
This filing indicates that Bluejay Diagnostics held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — This is a routine filing reporting on a vote of security holders, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-41031 — SEC File Number (Identifies the company's filing with the SEC)
- 47-3552922 — EIN (Employer Identification Number for tax purposes)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- June 20, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 360 Massachusetts Avenue, Suite 203, Acton, MA 01720 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Bluejay Diagnostics' security holders on or before June 18, 2025?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals voted upon in the provided text.
What is the significance of the filing date being June 20, 2025, while the earliest event reported is June 18, 2025?
This indicates that the corporate action or vote occurred on June 18, 2025, and the company is reporting it to the SEC within the required timeframe, with the filing officially made on June 20, 2025.
Where are Bluejay Diagnostics' principal executive offices located?
The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
In which state is Bluejay Diagnostics, Inc. incorporated?
Bluejay Diagnostics, Inc. is incorporated in Delaware.
What is the company's SEC file number?
The company's SEC file number is 001-41031.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).